[Ip-health] NIH responds (sort of) to questions about Petragen, Inc., a start-up company incorporated in the state of Delaware

Mohga Kamal-Yanni MohgaKY at access2healthcare.net
Fri Oct 9 13:18:38 PDT 2020


Jamie
You should frame it and put it up in your office and on twitter! 

Amazing.

Best Wishes  مع أطيب التمنيات 
Mohga

Dr. Mohga Kamal-Yanni MPhil. MBE
Global Health and Access to Medicines Consultant
Tel: +44 (0) 777 62 55 884
E mail: MohgaKY at access2healthcare.net
https://www.access2healthcare.net/

-----Original Message-----
From: Ip-health <ip-health-bounces at lists.keionline.org> On Behalf Of James Love
Sent: 09 October 2020 20:33
To: Ip-health <ip-health at lists.keionline.org>
Subject: [Ip-health] NIH responds (sort of) to questions about Petragen, Inc., a start-up company incorporated in the state of Delaware

This is how the NIH responds when asked questions about a proposed exclusive license to a company that has no web page or SEC filings.

---------- Forwarded message ---------
From: Williams, Benfeard (NIH/NHLBI) [E] <benfeard.williams at nih.gov>
Date: Fri, Oct 9, 2020 at 3:12 PM
Subject: RE: Petragen, Inc., a start-up company incorporated in the state of Delaware
To: James Love <james.love at keionline.org>
Cc: Claire Cassedy <claire.cassedy at keionline.org>, Kathryn Ardizzone < kathryn.ardizzone at keionline.org>, Luis Gil Abinader < luis.gil.abinader at keionline.org>


Dear Jamie Love,



Please find responses to your questions below.



   1. Can you tell us who are the principals in this company, which does
   not appear to have any web page or SEC filings?
      1. To the extent any of this information may be provided in the
      company’s application, it is protected as business confidential.
   2. Is there any foreign ownership in the company?
      1. To the extent any of this information may be provided in the
      company’s application, it is protected as business confidential.
   3. Is the NIH negotiating in parallel a waiver of US manufacturing?
      1. We cannot confirm or deny whether we are negotiating such
      agreements.
   4. What is the stage of development of this technology?  Have there been
   any clinical trials?
      1. This is an early stage technology. There have been no clinical
      trials.
   5. Will the NIH include any international reference pricing obligations
   on the company, given the President's campaign promises on this issue?
      1. The agreement and its royalty terms are yet to be negotiated and
      are confidential to the company.



Best regards,

Benfeard Williams



*---*

*Benfeard L. Williams, II, Ph.D.* | Office of Technology Transfer and Development

National Heart, Lung, and Blood Institute | National Institutes of Health

31 Center Drive, Room 4A29, MSC2479, Bethesda, MD 20892-2479

Email: benfeard.williams at nih.gov





*From:* James Love <james.love at keionline.org>
*Sent:* Thursday, September 24, 2020 9:03 AM
*To:* Williams, Benfeard (NIH/NHLBI) [E] <benfeard.williams at nih.gov>
*Cc:* Claire Cassedy <claire.cassedy at keionline.org>; Kathryn Ardizzone < kathryn.ardizzone at keionline.org>; Luis Gil Abinader < luis.gil.abinader at keionline.org>
*Subject:* Petragen, Inc., a start-up company incorporated in the state of Delaware




Dear Benfeard Williams, II, Ph.D,



1. Can you tell us who are the principals in this company, which does not appear to have any web page or SEC filings?



2.  Is there any foreign ownership in the company?



3. Is the NIH negotiating in parallel a waiver of US manufacturing?



4.  What is the stage of development of this technology?  Have there been any clinical trials?



5.  Will the NIH include any international reference pricing obligations on the company, given the President's campaign promises on this issue?



Jamie



-- 

James Love.  Knowledge Ecology International

U.S. Mobile +1.202.361.3040

U.S. office phone +1.202.332.2670
https://nam02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2F&data=02%7C01%7C%7Ce81c84d0949e42f1c8c608d86c8a63ab%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637378688913165688&sdata=sBqSNJSTEAKMTQzlzyuJNFX07aDqtN26Fm0KzPaYt5k%3D&reserved=0 <https://nam02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2Fdonate.html&data=02%7C01%7C%7Ce81c84d0949e42f1c8c608d86c8a63ab%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637378688913170677&sdata=gNLQoBEMMxxKzLFYHalwW4gFKzoChtLHL9cRgB0vDM4%3D&reserved=0>

twitter.com/jamie_love


--
James Love.  Knowledge Ecology International U.S. Mobile +1.202.361.3040 U.S. office phone +1.202.332.2670
https://nam02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2F&data=02%7C01%7C%7Ce81c84d0949e42f1c8c608d86c8a63ab%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637378688913170677&sdata=pXscfOrRuIsimH75Ama%2B%2B5c0oXjs6q4PnlZEG9IWkkk%3D&reserved=0 <https://nam02.safelinks.protection.outlook.com/?url=http%3A%2F%2Fwww.keionline.org%2Fdonate.html&data=02%7C01%7C%7Ce81c84d0949e42f1c8c608d86c8a63ab%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637378688913175669&sdata=MrEJ2%2BFF5230xqc2EAu3VZVusYBYwx%2BGenMZsLy57%2BM%3D&reserved=0>
twitter.com/jamie_love
_______________________________________________
Ip-health mailing list
Ip-health at lists.keionline.org
https://nam02.safelinks.protection.outlook.com/?url=http%3A%2F%2Flists.keionline.org%2Fmailman%2Flistinfo%2Fip-health_lists.keionline.org&data=02%7C01%7C%7Ce81c84d0949e42f1c8c608d86c8a63ab%7C84df9e7fe9f640afb435aaaaaaaaaaaa%7C1%7C0%7C637378688913175669&sdata=HdlXhrptrptMiqEjtHYExIxnxRrCqNpqtfON8YuYnsI%3D&reserved=0


More information about the Ip-health mailing list